Abubakar, Zamesa M.
HRN: 24-83-24 Sex: FemalePatient Encounter
AMS Audit List
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/02/2024
CEFTRIAXONE 1G (VIAL)
04/02/2024
04/08/2024
IV DRIP
2g
OD
Presumptive PTB; UTI
Checking Final Appropriateness
04/07/2024
CO-AMOXICLAV 625MG (TAB)
04/07/2024
04/09/2024
ORAL
625 Mg Tablet
2x A Day
Empiric
Checking Final Appropriateness